1. Home
  2. IMNM vs AXL Comparison

IMNM vs AXL Comparison

Compare IMNM & AXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • AXL
  • Stock Information
  • Founded
  • IMNM 2006
  • AXL 1994
  • Country
  • IMNM United States
  • AXL United States
  • Employees
  • IMNM N/A
  • AXL 19000
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • AXL Auto Parts:O.E.M.
  • Sector
  • IMNM Health Care
  • AXL Consumer Discretionary
  • Exchange
  • IMNM Nasdaq
  • AXL Nasdaq
  • Market Cap
  • IMNM 747.7M
  • AXL 739.6M
  • IPO Year
  • IMNM 2020
  • AXL 1999
  • Fundamental
  • Price
  • IMNM $12.09
  • AXL $6.30
  • Analyst Decision
  • IMNM Strong Buy
  • AXL Hold
  • Analyst Count
  • IMNM 4
  • AXL 5
  • Target Price
  • IMNM $28.75
  • AXL $7.10
  • AVG Volume (30 Days)
  • IMNM 761.5K
  • AXL 1.5M
  • Earning Date
  • IMNM 11-07-2024
  • AXL 11-01-2024
  • Dividend Yield
  • IMNM N/A
  • AXL N/A
  • EPS Growth
  • IMNM N/A
  • AXL N/A
  • EPS
  • IMNM N/A
  • AXL 0.01
  • Revenue
  • IMNM $10,784,000.00
  • AXL $6,254,100,000.00
  • Revenue This Year
  • IMNM N/A
  • AXL $3.41
  • Revenue Next Year
  • IMNM N/A
  • AXL N/A
  • P/E Ratio
  • IMNM N/A
  • AXL $738.16
  • Revenue Growth
  • IMNM 62.73
  • AXL 4.37
  • 52 Week Low
  • IMNM $6.93
  • AXL $5.43
  • 52 Week High
  • IMNM $30.96
  • AXL $8.99
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 36.69
  • AXL 55.25
  • Support Level
  • IMNM $11.81
  • AXL $5.91
  • Resistance Level
  • IMNM $12.44
  • AXL $6.17
  • Average True Range (ATR)
  • IMNM 0.68
  • AXL 0.16
  • MACD
  • IMNM -0.11
  • AXL 0.02
  • Stochastic Oscillator
  • IMNM 11.61
  • AXL 95.06

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.

About AXL American Axle & Manufacturing Holdings Inc.

American Axle & Mfg Holdings Inc is engaged in manufacturing, engineering, designing and validation of driveline systems and related components and chassis modules for light trucks, SUVs, crossover vehicles, passenger cars, and commercial vehicles. The company's segment includes Driveline and Metal Forming. It generates maximum revenue from the Driveline segment.

Share on Social Networks: